OBCHOD OBUVÍ ZLÍN, OBCHOD OBUVÍ, A.S. ZLÍN, Největší objemy, RM Systém
| Poehled kurzu cenných papíru - OBCHOD OBUVÍ ZLÍN | ||||||||||||||
  Datum | Kurz BCPP [Ke] | Zmina BCPP [%] | Objem BCPP [Ke] | Poeet BCPP [ks] | Kurz RMS [Ke] | Zmina RMS [%] | Objem RMS [Ke] | Poeet RMS [ks] |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.11.1995 | 75.00 | 0.00% | 0 | 0 | 70.00 | -6.00% | 3 850 | 55 | ||||||
| 24.1.1996 | 80.00 | 0.00% | 0 | 0 | 81.00 | -2.00% | 3 812 | 49 | ||||||
| 28.6.1996 | 77.00 | 0.00% | 0 | 0 | 79.10 | 0.00% | 3 797 | 48 | ||||||
| 13.12.1996 | 54.00 | 0.00% | 0 | 0 | 54.00 | 0.00% | 3 780 | 70 | ||||||
| 26.11.1996 | 60.00 | 0.00% | 2 220 | 37 | 60.00 | 0.00% | 3 780 | 63 | ||||||
| 14.10.1996 | 66.10 | 0.00% | 925 | 14 | 64.10 | +3.42% | 3 722 | 57 | ||||||
| 2.4.1997 | 72.30 | +1.54% | 4 989 | 69 | 62.00 | -0.95% | 3 720 | 60 | ||||||
| 30.4.1997 | 83.30 | +1.33% | 8 080 | 97 | 76.50 | +1.45% | 3 672 | 48 | ||||||
| 13.1.1997 | 54.00 | 0.00% | 0 | 0 | 52.00 | -3.70% | 3 640 | 70 | ||||||
| 26.3.1996 | 76.10 | 0.00% | 533 | 7 | 76.00 | -3.00% | 3 619 | 49 | ||||||
| 10.5.1995 | 105.00 | -277.00% | 8 190 | 78 | 102.50 | -2.00% | 3 588 | 35 | ||||||
| 6.2.1997 | 54.00 | 0.00% | 1 512 | 28 | 47.50 | -2.06% | 3 515 | 74 | ||||||
| 22.6.1995 | 80.00 | 0.00% | 960 | 12 | 100.00 | -5.00% | 3 500 | 35 | ||||||
| 6.11.1995 | 75.00 | +1.35% | 7 500 | 100 | 69.00 | 0.00% | 3 450 | 50 | ||||||
| 29.10.1996 | 62.80 | 0.00% | 0 | 0 | 61.10 | -4.68% | 3 422 | 56 | ||||||
| 9.11.1995 | 76.00 | +1.33% | 8 588 | 113 | 73.00 | -3.00% | 3 372 | 48 | ||||||
| 15.8.1996 | 73.40 | 0.00% | 0 | 0 | 76.10 | 0.00% | 3 348 | 44 | ||||||
| 20.5.1996 | 78.10 | 0.00% | 0 | 0 | 79.00 | +5.00% | 3 304 | 42 | ||||||
| 31.5.1996 | 79.00 | 0.00% | 11 692 | 148 | 79.10 | -1.00% | 3 273 | 42 | ||||||
| 17.3.1997 | 62.50 | +1.62% | 1 500 | 24 | 54.50 | 0.00% | 3 270 | 60 | ||||||
| ||||||||||||||
Okénko BIG EXPERT
Lukáš Hrma, ČSNF SICAV, a.s.
Tomáš Cverna, XTB
Léto bude pro akcie důležité, Evropa vyhlíží volby ve Francii
David Matulay, InvestingFox
Nejhodnotnější společnost v Evropě: Léky na obezitu společnosti Novo Nordisk jsou velmi žádané
Ing. Vladimír Pikora, Ph.D., Dluhopisomat
David Varga, Fintokei
Roman Vykouřil, Wonderinterest Trading s.r.o.
Vydrží koruna i nadále zpevňovat? Odpověď dostaneme brzy, záležet bude na ECB
